{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:07:27Z","timestamp":1791950847993,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jpba.2023.115457","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T17:16:57Z","timestamp":1684171017000},"page":"115457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Establishment of LC\u2013MS\/MS method for quantifying chlorpromazine metabolites with application to its metabolism in liver and placenta microsomes"],"prefix":"10.1016","volume":"233","author":[{"given":"Tiantian","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2023.115457_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/acschemneuro.8b00258","article-title":"Classics in chemical neuroscience: chlorpromazine","volume":"10","author":"Boyd-Kimball","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.jpba.2023.115457_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"L\u00f3pez-Mu\u00f1oz","year":"2005","journal-title":"Ann. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpba.2023.115457_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(86)90793-4","article-title":"Phenothiazine drug metabolites: dopamine D2 receptor, alpha 1- and alpha 2-adrenoceptor binding","volume":"125","author":"Hals","year":"1986","journal-title":"Eur. J. Pharm."},{"issue":"8","key":"10.1016\/j.jpba.2023.115457_bib4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.bcp.2010.06.045","article-title":"Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver--A comparison with other phenothiazines","volume":"80","author":"Wojcikowski","year":"2010","journal-title":"Biochem Pharm."},{"issue":"5","key":"10.1016\/j.jpba.2023.115457_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1601-5215.2011.00590.x","article-title":"Treatment of psychosis during pregnancy - a case report and a mini-review","volume":"23","author":"Nielsen","year":"2011","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jpba.2023.115457_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114403","article-title":"Chlorpromazine, an antipsychotic agent, induces G2\/M phase arrest and apoptosis via regulation of the PI3K\/AKT\/mTOR-mediated autophagy pathways in human oral cancer","volume":"184","author":"Jhou","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.jpba.2023.115457_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104809","article-title":"Treatment of cancer with antipsychotic medications: pushing the boundaries of schizophrenia and cancer","volume":"141","author":"Brown","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpba.2023.115457_bib8","series-title":"Extrapyramidal Symptoms","author":"D'Souza","year":"2023"},{"issue":"1","key":"10.1016\/j.jpba.2023.115457_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s13104-019-4398-6","article-title":"Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi","volume":"12","author":"Chikowe","year":"2019","journal-title":"BMC Res Notes"},{"issue":"7","key":"10.1016\/j.jpba.2023.115457_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/070674378002500707","article-title":"Untoward effects following combined neuroleptic-lithium therapy. Cardiac arrhythmias and seizure","volume":"25","author":"Menes","year":"1980","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jpba.2023.115457_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.134298","article-title":"Determination of chlorpromazine and its metabolites in animal-derived foods using QuEChERS-based extraction, EMR-Lipid cleanup, and UHPLC-Q-Orbitrap MS analysis","volume":"403","author":"Dai","year":"2023","journal-title":"Food Chem."},{"issue":"3","key":"10.1016\/j.jpba.2023.115457_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00007691-198709000-00018","article-title":"Therapeutic monitoring of chlorpromazine. IV: Comparison of a new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolites","volume":"9","author":"Midha","year":"1987","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.jpba.2023.115457_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0924-977X(95)00047-S","article-title":"Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels","volume":"6","author":"Chetty","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.jpba.2023.115457_bib14","first-page":"367","article-title":"Metabolism of psychotropic drugs: pharmacological and clinical relevance","volume":"47","author":"Daniel","year":"1995","journal-title":"Pol. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jpba.2023.115457_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(98)00005-4","article-title":"The use of a side effect as a qualitative indicator of plasma chlorpromazine levels","author":"Chetty","year":"1999","journal-title":"Eur. Neuropsychopharmacol. 9("},{"issue":"2","key":"10.1016\/j.jpba.2023.115457_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0024-3205(00)00613-5","article-title":"Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes","volume":"67","author":"Yoshii","year":"2000","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.jpba.2023.115457_bib17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.pnpbp.2007.05.013","article-title":"Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia","volume":"31","author":"Tay","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpba.2023.115457_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF00196109","article-title":"Smoking and body weight influence the clearance of chlorpromazine","volume":"46","author":"Chetty","year":"1994","journal-title":"Eur. J. Clin. Pharm."},{"issue":"5280","key":"10.1016\/j.jpba.2023.115457_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/229124a0","article-title":"Distribution of pethidine and chlorpromazine in maternal, foetal and neonatal biological fluids","volume":"229","author":"O'Donoghue","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2023.115457_bib20","article-title":"Effective extraction of organophosphorus pesticides using sol-gel based coated stainless steel mesh as novel solid-phase extraction sorbent","volume":"2020","author":"Amiri","year":"1620","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.jpba.2023.115457_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00604-017-2587-3","article-title":"A nanocomposite consisting of poly(methyl methacrylate), graphene oxide and Fe(3)O(4) nanoparticles as a sorbent for magnetic solid-phase extraction of aromatic amines","volume":"185","author":"Bashtani","year":"2017","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.jpba.2023.115457_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2016.08.034","article-title":"Magnetized graphene layers synthesized on the carbon nanofibers as novel adsorbent for the extraction of polycyclic aromatic hydrocarbons from environmental water samples","volume":"1465","author":"Rezvani-Eivari","year":"2016","journal-title":"J. Chromatogr. A"},{"issue":"6","key":"10.1016\/j.jpba.2023.115457_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5582\/ddt.2021.01101","article-title":"Quantification of antipsychotic biotransformation in brain microvascular endothelial cells by using untargeted metabolomics","volume":"15","author":"Ngamratanapaiboon","year":"2021","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.jpba.2023.115457_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpba.2019.05.063","article-title":"Evaluation of molecularly imprinted polymers for chlorpromazine and bromopromazine prepared by multi-step swelling and polymerization method-The application for the determination of chlorpromazine and its metabolites in rat plasma by column-switching LC","volume":"174","author":"Nishimura","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jpba.2023.115457_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/molecules24020310","article-title":"Butyl Methacrylate-Co-Ethylene glycol dimethacrylate monolith for online in-tube SPME-UHPLC-MS\/MS to determine chlopromazine, clozapine, quetiapine, olanzapine, and their metabolites in plasma samples","volume":"24","author":"Beloti","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2023.115457_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105281","article-title":"Risk assessment of the inhibition of hydroxygenkwanin on human and rat cytochrome P450 by cocktail method","volume":"79","author":"Gao","year":"2022","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.jpba.2023.115457_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxlet.2020.02.014","article-title":"Activities of metabolizing enzymes in human placenta","volume":"326","author":"Mohammed","year":"2020","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.jpba.2023.115457_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.dmpk.2014.09.006","article-title":"Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans","volume":"30","author":"Taniguchi-Takizawa","year":"2015","journal-title":"Drug Metab. Pharm."},{"issue":"1","key":"10.1016\/j.jpba.2023.115457_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3565(25)38813-0","article-title":"Inactivation of cytochrome P-450 by the drug methoxsalen","volume":"236","author":"Fouin-Fortunet","year":"1986","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.jpba.2023.115457_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122671","article-title":"Establishment of LC-MS\/MS method for determination of aloperine in rat plasma and its application in preclinical pharmacokinetics","volume":"1173","author":"Huang","year":"2021","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2023.115457_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113763","article-title":"Investigation of the content differences of arachidonic acid metabolites in a mouse model of breast cancer by using LC-MS\/MS","volume":"194","author":"Chen","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115457_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpba.2013.07.004","article-title":"Experiments for a systematic comparison between stable-isotope-(deuterium) labeling and radio-((14)C) labeling for the elucidation of the in vitro metabolic pattern of pharmaceutical drugs","volume":"85","author":"Grunwald","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.jpba.2023.115457_bib33","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3390\/molecules26092717","article-title":"A Validated LC-MS\/MS Assay for the Simultaneous Quantification of the FDA-Approved Anticancer Mixture (Encorafenib and Binimetinib): metabolic stability estimation","volume":"26","author":"Attwa","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2023.115457_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114729","article-title":"Analytical validation of a novel panel of biomarkers for a test for preeclampsia","volume":"214","author":"Hendershot","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2023.115457_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/17512433.2020.1733412","article-title":"The role of xenobiotic-metabolizing enzymes in the placenta: a growing research field","volume":"13","author":"Blanco-Castaneda","year":"2020","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"12","key":"10.1016\/j.jpba.2023.115457_bib36","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.bcp.2006.08.024","article-title":"Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons","volume":"72","author":"Ravindran","year":"2006","journal-title":"Biochem Pharm."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523002261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523002261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:29:22Z","timestamp":1760002162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523002261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"alternative-id":["S0731708523002261"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115457","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of LC\u2013MS\/MS method for quantifying chlorpromazine metabolites with application to its metabolism in liver and placenta microsomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115457"}}